Open for discussion, and I am sure this subject has been talked about before. BIEL at one time closed in the .12¢ range with pending FDA chatter.That was of course many moons ago and here we are with the FDA finally looking like they may reclassify this technology. So my questions are . . .
What does the PPS get to with just reclassification alone?
Where does it go if FDA approval is granted - and how likely is that with the relationship that Andy and the FDA have had in the past? Reclassification is one thing, but approval is another.
I know we have seen continued dilution and I am sure we have twice as many shares outstanding.
There seem to be several board contributors that have a handle on this company, and I would appreciate anyones thoughts.
BTW, I have owned three different patches and they are fantastic in cutting healing time in half.